What does Rhenman & Partners Asset Management AB hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

Rhenman & Partners Asset Management AB filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

BOSTON SCIENTIFIC CORP

$39M625K4.8%

REGENERON PHARMACEUTICALS

$37M48K4.6%

LILLY ELI & CO

$31M34K3.8%

INSMED INC

$26M160K3.2%

CVS HEALTH CORP

$24M337K3.0%

GILEAD SCIENCES INC

$23M168K2.9%

THERMO FISHER SCIENTIFIC INC

$20M41K2.5%

BIOGEN INC

$20M109K2.5%

VERTEX PHARMACEUTICALS INC

$19M43K2.4%

ALIGNMENT HEALTHCARE INC

$19M1.1M2.3%

Filing history loading…